These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21470203)

  • 21. Direct and indirect effects of cannabinoids on in vitro GABA release in the rat arcuate nucleus.
    Menzies JR; Ludwig M; Leng G
    J Neuroendocrinol; 2010 Jun; 22(6):585-92. PubMed ID: 20236227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.
    Dennis I; Whalley BJ; Stephens GJ
    Br J Pharmacol; 2008 Jul; 154(6):1349-58. PubMed ID: 18493244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones.
    Straiker A; Wager-Miller J; Hutchens J; Mackie K
    Br J Pharmacol; 2012 Apr; 165(8):2660-71. PubMed ID: 22014238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
    Olango WM; Roche M; Ford GK; Harhen B; Finn DP
    Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.
    Kangas BD; Delatte MS; Vemuri VK; Thakur GA; Nikas SP; Subramanian KV; Shukla VG; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2013 Mar; 344(3):561-7. PubMed ID: 23287700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
    Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
    Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
    Thompson SA; Whiting PJ; Wafford KA
    Br J Pharmacol; 1996 Feb; 117(3):521-527. PubMed ID: 8821543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.
    Alhamoruni A; Wright KL; Larvin M; O'Sullivan SE
    Br J Pharmacol; 2012 Apr; 165(8):2598-610. PubMed ID: 21745190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.
    Hudson BD; Hébert TE; Kelly ME
    Br J Pharmacol; 2010 Jun; 160(3):627-42. PubMed ID: 20590567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactive effects of AM251 and baclofen on synaptic plasticity in the rat dentate gyrus.
    Nazari M; Komaki A; Salehi I; Sarihi A; Shahidi S; Komaki H; Ganji A
    Brain Res; 2016 Nov; 1651():53-60. PubMed ID: 27663967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gamma-HCH and delta-HCH on human recombinant GABA(A) receptors: dependence on GABA(A) receptor subunit combination.
    Maskell PD; Wafford KA; Bermudez I
    Br J Pharmacol; 2001 Jan; 132(1):205-12. PubMed ID: 11156579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.
    Le Foll B; Forget B; Aubin HJ; Goldberg SR
    Addict Biol; 2008 Jun; 13(2):239-52. PubMed ID: 18482433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.
    Pertwee RG
    Life Sci; 2005 Feb; 76(12):1307-24. PubMed ID: 15670612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.
    Xi ZX; Gilbert JG; Peng XQ; Pak AC; Li X; Gardner EL
    J Neurosci; 2006 Aug; 26(33):8531-6. PubMed ID: 16914679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacological paradox: may a neutral antagonist shift an agonist concentration-response curve to the left?
    Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):601-3. PubMed ID: 24866501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
    Ralevic V; Kendall DA
    Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.